FDA Adverse Event Injury Summary report: N

MINICAP EXTEND LIFE PD TRANSFSET W/TWIST CLAMP

MDR report key: 1880641 · Received October 25, 2010

Report

Report Number
1423500-2010-04841
Event Type
Injury
Date Received
October 25, 2010
Date of Event
September 1, 2010
Report Date
October 3, 2010
Manufacturer
BAXTER HEALTHCARE - MOUNTAIN HOME
Product Code
KDJ
PMA / PMN Number
K882498
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). A SAMPLE IS AVAILABLE.

Additional Manufacturer Narrative · 1

(B)(4). THE ROOT CAUSE COULD NOT BE DETERMINED. A BATCH REVIEW WAS PERFORMED FOR POTENTIALLY ASSOCIATED LOT (H10D30064) WITH NO ISSUES NOTED DURING THE MANUFACTURING PROCESS. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. THE ROOT CAUSE INVESTIGATION IS IN PROGRESS.

Description of Event or Problem · 1

ON AN UNREPORTED DATE, THE PATIENT BEGAN TREATMENT WITH DIANEAL PD2 AMBUFLEX (DOSE, FREQUENCY) INTRAPERITONEALLY (IP) FOR PERITONEAL DIALYSIS (PD). DURING A CALL WITH BAXTER CUSTOMER SERVICES, THE NURSE STATED THAT ON AN UNREPORTED DATE IN 2010, THE PATIENT'S "DRAIN BAG CAME BACK CLOUDY". ON (B)(6) 2010, THE PATIENT WAS DIAGNOSED WITH PERITONITIS AND HOSPITALIZED THAT SAME DAY. THE CAUSE OF THE PERITONITIS AND CLOUDY DRAIN BAG WERE UNKNOWN. TREATMENT INFORMATION WAS NOT PROVIDED. DIANEAL THERAPY WAS ONGOING. THE NURSE ANTICIPATED THAT THE PATIENT WOULD BE DISCHARGED ON (B)(6) 2010. THE PATIENT WAS RECOVERING. PER THE NURSE, THE EVENT OF PERITONITIS WAS NOT RELATED TO DIANEAL PD2 AMBUFLEX THERAPY.

Description of Event or Problem · 1

DURING A CALL FOR AN UNRELATED ALARM, THE PATIENT INDICATED HE HAD PERITONITIS. FOLLOW-UP INFORMATION OBTAINED ON (B)(4) 2010 BY GLOBAL PHARMACOVIGILANCE IS AS FOLLOWS: ON (B)(6) 2006, THE PATIENT BEGAN PD THERAPY USING PD4 AMBUFLEX, INTRAPERITONEAL (IP). THE PATIENT'S MOST RECENT DOSE OF PD4 AMBUFLEX WAS 10.5 LITERS NIGHTLY. ON (B)(6) 2010, THE PATIENT DEVELOPED AN EXIT SITE INFECTION. CULTURE RESULTS REVEALED A YEAST INFECTION. THE PATIENT WAS NOT HOSPITALIZED FOR THE EVENT. THE PATIENT WAS TREATED WITH FLUCONAZOLE FOR 3 WEEKS. THE EVENT OF EXIT SITE INFECTION WAS CONSIDERED RESOLVED AFTER FLUCONAZOLE THERAPY WAS COMPLETED. THE EVENT OF EXIT SITE INFECTION WAS NOT RELATED TO THE DIANEAL SOLUTION OR HOMECHOICE MACHINE. THE REPORTER DID NOT PROVIDE HER OPINION AS TO HOW THE PATIENT DEVELOPED THE EXIT SITE INFECTION. THE PATIENT REMAINED ON PD THERAPY. ON (B)(6) 2010, THE PATIENT WAS HOSPITALIZED FOR PERITONITIS. ON (B)(6) 2010, CULTURE RESULTS REVEALED STAPHYLOCOCCUS COAGULASE NEGATIVE. THE PATIENT WAS TREATED WITH IP ANTIBIOTICS. WHILE HOSPITALIZED THE PATIENT DEVELOPED TRANSIT ISCHEMIC ATTACKS (TIA) AND THE PATIENT WAS THOUGHT TO OF HAD A STROKE. WHEN ASKED IF THE REPORTER COULD PROVIDE SYMPTOMS THE PATIENT EXPERIENCED THE NURSE REPLIED, "SLUGGISH, NOT THINKING CLEARLY AND DELAYED RESPONSE." ON (B)(6) 2010, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. ON (B)(6) 2010, THE PATIENT HAD HIS TRANSFER SET REPLACED. AT THE TIME OF THIS REPORT THE EVENT OF PERITONITIS AND TIA WITH POSSIBLE STROKE WAS CONSIDERED ONGOING AND IMPROVED. THE NURSE STATED THE EVENT OF PERITONITIS AND TIA WITH POSSIBLE STROKE WAS NOT RELATED TO THE DIANEAL SOLUTIONS, TRANSFER SET OR HOMECHOICE MACHINE. THE PATIENT REMAINED ON PD THERAPY, DOSE NOT CHANGED. THE NURSE STATED THERE WAS NO RELATION OF THE SEPTEMBER PERITONITIS AND AUGUST EXIT SITE INFECTION. NO FURTHER INFORMATION IS AVAILABLE. THE FOLLOWING IS A POTENTIALLY ASSOCIATED LOT FOR THIS PERITONITIS EVENT: TRANSFER SET LOT H10D30064.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MINICAP EXTEND LIFE PD TRANSFSET W/TWIST CLAMP SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE - MOUNTAIN HOME

Patients

Seq Age Sex Outcome Treatment
1 46 YR Hospitalization| R PD4 AMBUFLEX